AAAAAA

   
Results: 1-9 |
Results: 9
Feminizing genitoplasty in patients with 46XX congenital adrenal hyperplasia
Authors: Farkas, A Chertin, B
Citation: A. Farkas et B. Chertin, Feminizing genitoplasty in patients with 46XX congenital adrenal hyperplasia, J PED END M, 14(6), 2001, pp. 713-722
Endoscopic puncture of ureterocele as a minimally invasive and effective long-term procedure in children
Authors: Chertin, B Fridmans, A Hadas-Halpren, I Farkas, A
Citation: B. Chertin et al., Endoscopic puncture of ureterocele as a minimally invasive and effective long-term procedure in children, EUR UROL, 39(3), 2001, pp. 332-336
Effective long-term androgen suppression in men with prostate cancer usinga hydrogel implant with the GnRH agonist histrelin
Authors: Schlegel, PN Kuzma, P Frick, J Farkas, A Gomahr, A Spitz, I Chertin, B Mack, D Jungwirth, A King, P Nash, H Bardin, CW Moo-Young, A
Citation: Pn. Schlegel et al., Effective long-term androgen suppression in men with prostate cancer usinga hydrogel implant with the GnRH agonist histrelin, UROLOGY, 58(4), 2001, pp. 578-582
1-stage feminizing genitoplasty: 8 years of experience with 49 cases
Authors: Farkas, A Chertin, B Hadas-Halpren, I
Citation: A. Farkas et al., 1-stage feminizing genitoplasty: 8 years of experience with 49 cases, J UROL, 165(6), 2001, pp. 2341-2346
Transabdominal pelvic sonography in the preoperative evaluation of patients with congenital adrenal hyperplasia
Authors: Chertin, B Hadas-Halpern, I Fridmans, A Kniznik, M Abu-Arafeh, W Zilberman, M Farkas, A
Citation: B. Chertin et al., Transabdominal pelvic sonography in the preoperative evaluation of patients with congenital adrenal hyperplasia, J CLIN ULTR, 28(3), 2000, pp. 122-124
An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer
Authors: Chertin, B Spitz, IM Lindenberg, T Algur, N Zer, T Kuzma, P Young, AJM Catane, R Farkas, A
Citation: B. Chertin et al., An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer, J UROL, 163(3), 2000, pp. 838-844
Laser prostatectomy - Long-term follow-up of 303 patients
Authors: Chertin, B Moriel, EZ Hadas-Halperin, I Abu-Arafeh, W Lupa, S Zilberman, M Farkas, A
Citation: B. Chertin et al., Laser prostatectomy - Long-term follow-up of 303 patients, EUR UROL, 35(4), 1999, pp. 285-288
Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer
Authors: Spitz, IM Chertin, B Lindenberg, T Farkas, A
Citation: Im. Spitz et al., Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer, N ENG J MED, 340(18), 1999, pp. 1439-1439
Does early detection of ureteropelvic junction obstruction improve surgical outcome in terms of renal function?
Authors: Chertin, B Fridmans, A Knizhnik, M Hadas-Halperin, I Hain, D Farkas, A
Citation: B. Chertin et al., Does early detection of ureteropelvic junction obstruction improve surgical outcome in terms of renal function?, J UROL, 162(3), 1999, pp. 1037-1040
Risultati: 1-9 |